Robert Charles Breedlove's most recent trade in Phathom Pharmaceuticals Inc was a trade of 33,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phathom Pharmaceuticals Inc | Robert Charles Breedlove | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 33,000 | 33,000 | - | - | Stock Option (Right to Buy) |